Piramal Enterprises’ business unit launches MITIGO in US market

12 Mar 2019 Evaluate

Piramal Enterprises’ business unit -- Piramal Critical Care has launched MITIGO (Morphine Sulfate Injection, USP - Preservative-free) in 10 mg/mL and 25 mg/mL concentrations in the US market. Piramal Critical Care will continue to work with wholesalers, hospitals, interventional pain doctors, and pain management centers across the country to ensure availability of MITIGO for patients with intractable chronic pain.

MITIGO is an opioid agonist, for use in continuous microinfusion devices indicated only for intrathecal or epidural infusion for the management of intractable chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Available in 200 mg/20 mL (10 mg/mL) and 500 mg/20 mL (25 mg/mL) preservative-free amber glass vials.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 950.50
Shriram Finance 995.55
Aditya Birla Capital 361.70
Chola Invest & Fin. 1699.45
Tata Capital 358.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×